Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.

Cochrane database of systematic reviews (Online)

Volumn 9, Issue , 2012, Pages

  Katz, Lior H ^a   Goldvaser, Hadar ^b   Gafter Gvili, Anat ^b   Tur Kaspa, Ran ^b  

^a MD Anderdson Cancer Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT PROTEIN; RIBAVIRIN;

ADULT; DRUG ADMINISTRATION; DRUG COMBINATION; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; POLYETHYLENE GLYCOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; RIBAVIRIN; TIME FACTORS; VIRAL LOAD;

EID: 84873029732     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)